Psychoses

17 registered clinical trials studyying Psychoses — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Adapting a Socio-cognitive Intervention to Early Psychosis Services NCT07102784	King's College London	—
Completed	Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness NCT06960811	Central Hospital, Nancy, France	—
Completed	Patient-controlled Admissions in Inpatient Mental Health Services NCT03609515	University Hospital, Akershus	N/A
Completed	Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland NCT01196858	University Hospital of North Norway	—
Completed	D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia NCT00960219	China Medical University Hospital	Phase 2
Unknown	DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics NCT00752960	Genomas, Inc	—
Withdrawn	Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia NCT00276263	Herzog Hospital	Phase 2
Completed	Pharmacy Interventions to Improve Chronic Disease Medication Refill NCT00469365	Medical University of South Carolina	Phase 3
Completed	Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia NCT00491569	China Medical University Hospital	Phase 2
Completed	Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia NCT00328276	China Medical University Hospital	Phase 2
Unknown	Access, Detection and Psychological Treatments NCT00260273	Ontario Mental Health Foundation	N/A
Completed	Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug NCT00087542	ACADIA Pharmaceuticals Inc.	Phase 2
Completed	Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease NCT00095810	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 4
Completed	Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia NCT00159133	Heinrich-Heine University, Duesseldorf	Phase 4
Completed	Maintenance Treatment vs. Stepwise Drug Discontinuation in First-Episode Schizophrenia NCT00159120	Heinrich-Heine University, Duesseldorf	Phase 4
Completed	Early Pharmacological and Psychological Intervention for Late Prodromal States of Psychosis NCT00204061	University of Cologne	Phase 4
Completed	Brain Cell Injury in Patients With A First Episode of Psychosis NCT00070889	National Center for Complementary and Integrative Health (NCCIH)	—